Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Nov 6, 2019, after the close
10-Q filed Nov 6, 2019, 37 days after period end · 0000320017-19-000086
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | — | — | — | $9.32M |
| Net Income | -$4.90M | -$3.55M | -$3.55M | -$7.29M |
| EPS Diluted |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.47 |
| -$0.36 |
| -$0.38 |
| -$1.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
